Regulating Preimplantation Genetic Diagnosis in the United States: The Limits of Unlimited Selection
Michelle Bayefsky and Bruce Jennings
(Palgrave Macmillan, 2015)
During medically assisted reproduction, preimplantation genetic diagnosis (PGD) can be used to select some embryos for use and to discard others based on their genetic characteristics. The practice of PGD is increasing as genetic testing becomes less expensive and reproductive technologies become more sophisticated, raising difficult ethical questions. The technique is regulated in nearly all other Western countries, but remains unregulated in the United States. As a result, it can and has been used to select for traits such as sex and deafness, as well as children who will be good tissue donors for sick older siblings. This book is a comprehensive and comparative study of the ethics and regulation of PGD. Authors Bruce Jennings, a senior advisor to The Hastings Center, and Michelle Bayefsky, a predoctoral fellow in the Bioethics Department of the National Institutes of Health, lay out the competing moral views at stake and analyzes whether and how PGD ought to be regulated in the US in light of current medical, political, and economic realities.
Purchase from Palgrave Macmillan
Purchase from Amazon